Serum hepcidin potentially identifies iron deficiency in survivors of critical illness at the time of hospital discharge

Br J Haematol. 2019 Jan;184(2):279-281. doi: 10.1111/bjh.15067. Epub 2018 Jan 24.

Akshay Shah¹, Katherine Wray², Timothy James³, Brian Shine³, Reza Morovat³, Simon Stanworth⁴, Stuart McKechnie¹, Rachael Kirkbride⁵, David M Griffith^{6

5}, Timothy S Walsh^{6

5}, Hal Drakesmith^{2

7}, Noémi Roy⁸

¹ Nuffield Department of Anaesthetics, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
² MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
³ Department of Clinical Biochemistry, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
⁴ NHS Blood and Transplant, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
⁵ Department of Anaesthesia, Critical Care and Pain Medicine, University of Edinburgh, Edinburgh, UK.
⁶ MRC Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
⁷ Biomedical Research Centre Blood Theme, NIHR Oxford Biomedical Research Centre, Oxford, UK.
⁸ MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

No abstract available

Keywords: anaemia; hepcidin; intensive care; iron deficiency.

Publication types